m.dalgaard

TL3 Regular · Odense, DK

Health economist by training, which mostly means I am tedious about cost-effectiveness claims.

Joined 26 December 2024 · last posted 1d · groups: journal-club, translators

1 reply marked as the accepted answer.

SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #6 · marked as the solution · Compounds › Tirzepatide · 18 Oct 2025 · 13 likes Worth separating two things that post #2 runs together. Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak.…